We reviewed 721 consecutive samples submitted for measurement of prostate-specific antigen (PSA) over five months. We identified three patients with extremely high PSA concentrations: 650, 1840, and 3280 /L (their acid phosphatase activities were 3.2, 1337, and 2.8 U/L, respectively), and present case reports for the latter two. Serial dilutions of samples obtained from the patient with the highest PSA concentration indicated that the one-step Tandem#{174}-PSA assay gave falsely low values for high concentrations of PSA, an observation consistent with the phenomenon of the "hook effect." This effect was not observed when the sample was reanalyzed for PSA by a two-step procedure.
Case 1
A 60-year-old man presented at a primary care center with gross hematuria without complaint of obstructive uropathy. Physical examination revealed an enlarged, mobile, benign-feeling prostate without any evidence of pelvic mass or fixation. Computerized tomographic scan revealed an enlarged prostate and the seTc bone scan demonstrated multiple metastases. Total acid phosphatase activity in serum was 1089 UIL (normal range, 0-0.7 U/L), but needle biopsies of the left and the right lobes of the prostate showed no malignancy. However, because of continued suspicion of prostatic malignancy, the patient was transferred to Barnes Hospital for further evaluation. Laboratory values before rectal examination confirmed the high activity of total acid phosphatase (1337 U/L) and showed a high concentration 
Materials and Methods
We measured acid phosphatase as described by Roy et al. We measured PSA by an immunoradiometric (sandwich) assay (Tandem#{174}-PSA; Hybritech Inc., La Jolla, CA) involving two monoclonal antibodies that recognize different epitopes on the PSA molecule. We performed this assay in one step as recommended by the manufacturer or modified it to two steps. In the modified assay, we incubated the antibodycoated bead for 2 h at room temperature with 50 A.L of samples or standards and 200 pL of phosphate-buffered saline containing bovine serum albumin (PBS-BSA; 50 mmol NaPO4, 0.15 mol NaC1, and 10 g bovine serum albumin per liter ofde-ionized water, pH 7.4). After washing the beads twice with 1 mL ofthe kit's washing solution, we incubated them with 200 zL of 1mIlabeled anti-PSA antibody (276 985 counts/mm) and 50 L ofPBS-BSA for 90 min at room temperature. We then washed the beads again, as described above, and measured with a gamma-counter the radioactivity bound to the beads.
Results by the two-step procedure varied 
Results and DIscussIon
Although histological examination of the prostate is required to establish the diagnosis of adenocarcinoma, needle biopsy can miss an area of malignancy (9), as occurred in Case 1. Consequently, serum values of the markers for prostatic cancer (e.g., acid phosphatase and PSA) can help support the diagnosis (4-6). Serial measurement of PSA (10), the most specific marker for prostatic carcinoma (2,3, 5,6), can be very useful in monitoring the progression of the 240 cancer and the success of therapy. To our knowledge, the highest published value for PSA is 600 g/L (5). However, in a five-month period, involving 721 measurements, we found 28 cases with PSA >100 tg/L and three cases with PSA >600 zg/L: 650, 1840, and 3280 zg/L. Given this high frequency of samples with high PSA, we investigated whether such high concentrations could pose any analytical problem. We found that measuring high concentrations ofPSA by a one-step immunoradiometric assay could potentially prosent an analytical problem. As shown in Figure la , serum samples from the patient described in Case 2 gave an apparently lower PSA value when undiluted (Sample A, 106 tgfL; Sample B, 184 g/L) than when diluted 5-or 40-fold (Sample A, >1020 zg/L; Sample B, 3280 pg/L). Because the PSA value of the undiluted Sample A was very close to the upper limit of linearity of the assay (100 ig/L), we considered that a major underestimation could have occurred. The measured PSA concentration in samples that were diluted as much as fivefold increased with increasing dilution (decreasing concentration ofPSA). These results are consistent with the phenomenon ofthe "hook effect," in which high concentrations of an analyte give an artifactually lower value when measured by sandwich assays. This effect has been attributed to heterogeneity in the affinity of the immobilized antibody, inadequate washing, or insufficient concentration of labeled antibody (11-14).
To confirm that the "hook effect" was involved in our observations we modified the Tandem-PSA assay to a twostep procedure and assayed a serum sample (PSA concentraton 6600 tg/L) from a new patient with prostatic cancer.
We assayed several dilutions ofthis sample with either the one-step or the two-step assay. As shown in Figure ib , the measured PSA concentration obtained in the undiluted duplicate samples by one-step assay were 78 and 121 tg/L (average 99 igfL). One of the two PSA values and the average PSA concentration were within the linearity range of the assay (100 ig/L). On the other hand, the duplicate PSA values obtained with undiluted sample by the two-step assay were 207 and 220 .tg/L (average 214 gfL). These results suggest that the one-step Tandem-PSA assay can give artifactually lower values in samples with extremely high concentrations of PSA, and that this artifact can be prevented by modifying the Tandem-PSA assay to a twostep procedure.
Alternatively, samples should be analyzed before and after dilution to be certain that erroneously low values are not reported. We currently use the latter procedure in our hospital. Our experience suggests that high PSA values are not rare, and that users ofthe Tandem-PSA assay should be aware of this potential analytical problem.
